• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Diabetes

Breaking: Sequel to launch twiist automated insulin delivery system next month

June 21, 2025 By Sean Whooley

sequel twiist automated insulin delivery AID system

Sequel Med Tech announced at the American Diabetes Association’s 85th Scientific Sessions in Chicago that it plans to launch its twiist system in July. Dr. Joanna Mitri, the company’s chief medical officer, shared the update in a Product Theater session at ADA today. Mitri said the company plans to launch the automated insulin delivery system […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: ADA 2025, Sequel Med Tech

Dexcom shares U.S. report on CGM benefits for type 2 diabetes

June 21, 2025 By Sean Whooley

Dexcom G7 CGM Apple Watch direct-to-watch

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S. The company released its report — “Dexcom State of Type 2 Report: Access and Attitudes Across the United States” — ahead of the American Diabetes Association’s 85th Scientific Sessions in Chicago. Findings provide insights into perceptions around […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: ADA 2025, Dexcom

Study backs Tandem automated insulin delivery in pregnant women with type 1 diabetes

June 20, 2025 By Sean Whooley

Tandem Diabetes Care t:slim 2 Control-IQ artificial pancreas

A new study showed improved glucose control in pregnant women using Tandem Diabetes Care (Nasdaq:TNDM) insulin delivery technology. The study showed that pregnant women with type 1 diabetes stayed in the target glucose range for pregnancy more with the Tandem t:slim X2 automated insulin delivery system with Control-IQ technology compared to standard insulin delivery with injections […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology, Women's Health Tagged With: ADA 2025, Tandem Diabetes Care

Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications

June 20, 2025 By Sean Whooley

Medtronic Simplera Sync CGM with MiniMed 780G (1)

Medtronic (NYSE:MDT) today shared data supporting the use of its MiniMed 780G automated insulin delivery system in a range of patients. The medtech giant highlighted improved glycemic outcomes for those with type 2 diabetes and in young children. Investigators shared data at the American Diabetes Association’s 85th Scientific Sessions in Chicago. In one study, participants […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Pediatrics, Technology Tagged With: ADA 2025, Medtronic

Abbott could pave new roads in diabetes management with dual sensor on the horizon

June 20, 2025 By Sean Whooley

Abbott FreeStyle Libre 3 sensor pennies CGM diabetes

About three years ago, Abbott (NYSE:ABT) announced that it had a new diabetes-related biowearable under development. The technology — a dual sensor that continuously monitors glucose and ketone levels — already had FDA breakthrough device designation. Abbott said at the time that it was set for pivotal trial use in 2023, with regulatory submissions to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, ADA 2025

Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.

June 20, 2025 By Sean Whooley

Tandem t_slim X2 Abbott FreeStyle Libre 3

Tandem Diabetes Care (Nasdaq:TNDM) announced today that its t:slim X2 system now works with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus. This marks the latest pairing of automated insulin delivery (AID) and continuous glucose monitor (CGM) technologies between the companies. They announced the integration of FreeStyle Libre 2 Plus CGM into the t:slim X2 insulin pump in […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Tandem Diabetes Care

Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system

June 20, 2025 By Sean Whooley

mylife loop camdiab ypsomed abbott freestyle libre 3

Ypsomed and CamDiab announced today that they agreed to integrate their mylife Loop automated insulin delivery system with a future Abbott (NYSE:ABT) sensor. The companies plan to pair their pump system with the Abbott dual glucose-ketone sensor, currently under development. Ypsomed and CamDiab join three other companies set to pair their pumps with the sensor after Abbott recently […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, CamDiab, Ypsomed

PharmaSens, SiBionics collab on all-in-one insulin patch pump

June 19, 2025 By Sean Whooley

PharmaSens Niia Essential insulin patch pump

PharmaSens today announced a strategic partnership with SiBionics to jointly develop an all-in-one insulin patch pump. Switzerland-based PharmaSens develops the Niia Essential insulin patch pump system. The basal-bolus patch pump combines the ease of an insulin pen with the advantages of a sophisticated pump. The company submitted the pump to the FDA at the end […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: PharmaSens, SiBionics

Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor

June 19, 2025 By Sean Whooley

Beta Bionics iLet bionic pancreas with Dexcom G7 and Abbott FreeStyle Libre 3 Plus

Beta Bionics (Nasdaq:BBNX) announced today that it agreed to integrate its iLet bionic pancreas with a future dual sensor from Abbott (NYSE:ABT). The agreement pairs the iLet automated insulin delivery system with the sensor designed to continuously monitor glucose and ketone levels. This marks the third such integration for the Abbott dual sensor. The company […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Beta Bionics

CeQur hits insulin patch milestone, highlights commercial expansion

June 18, 2025 By Sean Whooley

CeQur Simplicity insulin delivery patch (1)

CeQur announced today that it reached the milestone of 10 million mealtime insulin injections replaced with its Simplicity insulin patch. Horw, Switzerland began a pilot commercial launch for the FDA-cleared and CE-marked device in early 2021. In April 2021, the company raised $115 million to support that launch and scale up manufacturing. Since then, it says […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel Tagged With: cequr

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 164
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS